*  Intravenous Amrinone: An Advance or a Wrong Step? | Annals of Internal Medicine | American College of Physicians
Amrinone is advertised as a "major advance" in inotropic therapy because of its alleged advantages of more sustained action ... Intravenous Amrinone: An Advance or a Wrong Step?. Ann Intern Med. 1985;102:399-400. doi: 10.7326/0003-4819-102-3-399 ... Amrinone is a nonglycosidic, non-catecholamine-dependent, inotropic vasodilator agent that has recently been made available for ... Intravenous Amrinone: An Advance or a Wrong Step? JOSEPH A. FRANCIOSA, M.D. ...
  http://annals.org/aim/article-abstract/699502/intravenous-amrinone-advance-wrong-step
*  The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.
... ... The platelet count was significantly and variably reduced in all patients and the reduction was related to log plasma amrinone ... In a prospective trial, the immediate and long-term haematological effects of amrinone were studied in sixteen patients with ...
  http://erepository.uonbi.ac.ke:8080/xmlui/handle/11295/28477
*  Amrinone - Wikipedia
Both inotropic and lusitropic effects are the reason why amrinone is used to treat heart failure. Amrinone decreases the ... There is a net decrease in myocardial wall tension, and O2 consumption when using amrinone. Amrinone also has beneficial ... Amrinone has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR ... Amrinone should only be diluted with normal saline or 1/2 normal saline; no dextrose solutions should be used. Furosemide ...
  https://en.wikipedia.org/wiki/Amrinone
*  Amrinone lactate - Biology-Online Dictionary
Amrinone lactate 5-Amino-(3,4'-bipyridin)-6(1H)-one;an inotropic agent with vasodilator activity, used in management of ... Retrieved from "https://www.biology-online.org/dictionary/index.php?title=Amrinone_lactate&oldid=38748" ...
  https://www.biology-online.org/dictionary/Amrinone_lactate
*  Part 6: Advanced Cardiovascular Life Support | Circulation
Amrinone and Milrinone. Amrinone and milrinone are phosphodiesterase III inhibitors that have inotropic and vasodilatory ... Amrinone is administered as a dose of 0.75 mg/kg given initially over 2 to 3 minutes, followed by an infusion of 5 to 15 μg/kg ... Amrinone has a more significant effect on preload than catecholamines, and the hemodynamic effects are similar to those of ... Like amrinone, milrinone has a relatively long plasma half-life, which makes dose titration more difficult. Milrinone may also ...
  http://circ.ahajournals.org/content/102/suppl_1/I-129.full
*  Patente US6987129 - Compounds and methods for the treatment of urogenital disorders - Google Patentes
The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and/or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, α-adrenergic receptor antagonists, β-adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators, estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists,
  http://www.google.es/patents/US6987129
*  Cardiology - Drugs| Medindia
Amrinone. Antiarrhythmic Agent Dobutamine Antiarrhythmic Agent Digoxin Antiarrhythmic Agent Dopamine Antiarrhythmic Agent ...
  http://www.medindia.net/drugs/speciality/cardiology.htm
*  UniProt: P01375
DR DrugBank; DB01427; Amrinone. DR DrugBank; DB05676; Apremilast. DR DrugBank; DB05066; AV411. DR DrugBank; DB08904; ...
  http://www.genome.jp/dbget-bin/www_bget?uniprot:P01375
*  Nitroprusside - DrugBank
Amrinone. Amrinone may increase the hypotensive activities of Nitroprusside.. Approved. Amyl Nitrite. The risk or severity of ...
  https://www.drugbank.ca/drugs/DB00325
*  Miltefosine - DrugBank
Amrinone. The therapeutic efficacy of Miltefosine can be increased when used in combination with Amrinone. ...
  https://www.drugbank.ca/drugs/DB09031
*  Benzoic Acid - DrugBank
Amrinone. The risk or severity of adverse effects can be increased when Benzoic Acid is combined with Amrinone.. Approved. ...
  https://www.drugbank.ca/drugs/DB03793
*  Tolazoline - DrugBank
Amrinone. The risk or severity of hypotension can be increased when Tolazoline is combined with Amrinone.. Approved. ...
  https://www.drugbank.ca/drugs/DB00797
*  Capric acid - DrugBank
Amrinone. The therapeutic efficacy of Capric acid can be increased when used in combination with Amrinone.. Approved. ...
  https://www.drugbank.ca/drugs/DB03600
*  WHOCC - DDD alterations
Amrinone. 0.15. g. P. 0.5. g. P. C01CE01. 1991 Folic acid. 0.3 8). mg. O. 0.4. mg. O. B03BB01. 2003 ...
  https://www.whocc.no/atc_ddd_alterations__cumulative/ddd_alterations/?order_by=4&d=DESC
*  Welcome to HoPaCI
2013 - Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH) Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany. Disclaimer: MIPS Databases and associated information are protected by copyright. This server and its associated data and services are for academic, non-commercial use only. The Helmholtz Zentrum München has no liability for the use of results, data or information which have been provided through this server. Neither the use for commercial purposes, nor the redistribution of MIPS database files to third parties nor the distribution of parts of files or derivative products to any third parties is permitted.. ...
  http://mips.helmholtz-muenchen.de/HoPaCI/entry/show/3688?iList=35430&term=%26quot%3BTNF%26quot%3B&refFieldSingle=Gene%2FProtein%2FComplex
*  WHOCC - DDD alterations
Amrinone. 0.15. g. P. 0.5. g. P. C01CE01. 1991 Isoprenaline. 60. mg. O,P. 90. mg. O,P. C01CA02. 1987 ...
  https://www.whocc.no/atc_ddd_alterations__cumulative/ddd_alterations/?order_by=7&d=DESC
*  PDE3 inhibitor - Wikipedia
Amrinone, milrinone and enoximone are used clinically for short-term treatment of cardiac failure in the presence of ... Approved PDE3 inhibitors include the following: amrinone cilostazol milrinone enoximone pimobendane (approved for use in dogs) ...
  https://en.wikipedia.org/wiki/PDE3_inhibitor
*  Antihypotensive agent - Wikipedia
Reboxetine Venlafaxine Positive inotropic agents Cardiac glycosides Strophantin K Corglycon Digoxin Others Amrinone Milrinone " ...
  https://en.wikipedia.org/wiki/Antihypotensive_agent
*  List of MeSH codes (D03) - Wikipedia
... amrinone MeSH D03.383.725.050.085.543 --- milrinone MeSH D03.383.725.050.440 --- methapyrilene MeSH D03.383.725.050.610 --- ...
  https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D03)
*  Schedule H - Wikipedia
Amrinone Lactate Analgin Androgenic, Anabolic, Oestrogenic and Progestational Substances Antibiotics Aprotinin Organic Compound ...
  https://en.wikipedia.org/wiki/Schedule_H